Table 1 Baseline clinical characteristics of the two advanced gastric cancer patient groups before chemotherapy
Item | Number of patients | Experimental group | Control group | P |
|---|---|---|---|---|
Gender | 120 | 60 | 60 | |
Male | 85 | 42 | 43 | 1 |
Female | 35 | 18 | 17 | |
Age | ||||
≤ 35 | 28 | 13 | 15 | 0.829 |
36 to 70 | 92 | 47 | 45 | |
Phase | ||||
III C | 42 | 22 | 20 | 0.848 |
IV | 78 | 38 | 40 | |
Tumor location | ||||
Proximal stomach | 28 | 15 | 13 | 1 |
Gastric body | 40 | 18 | 22 | |
Distal stomach | 52 | 27 | 25 | |
ECOG score | ||||
0 to 1 | 46 | 24 | 22 | 0.851 |
2 | 74 | 36 | 38 | |
Pathological type | ||||
Well differentiated | 16 | 7 | 9 | 0.8 |
Moderately differentiated | 28 | 15 | 13 | |
Poorly differentiated | 76 | 38 | 38 |